Real-time
Other stock markets
|
5-day change | 1st Jan Change | ||
2.215 EUR | -0.89% | +3.02% | -15.46% |
Apr. 15 | Sanofi: progress in hematology trial | CF |
Apr. 15 | Innate Pharma: progress in hematology trial | CF |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-15.46% | 193M | |
+4.09% | 43.84B | |
+46.23% | 41.25B | |
+9.45% | 41.68B | |
-10.92% | 27.04B | |
+9.32% | 25.53B | |
-24.87% | 18.18B | |
+29.70% | 12.29B | |
+1.28% | 12.29B | |
+7.78% | 11.15B |
- Stock Market
- Equities
- IPH Stock
- News Innate Pharma
- Innate Pharma S A : SVB Leerink Downgrades Innate Pharma to Market Perform From Outperform, Adjusts Price Target to $5 From $7